Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |